Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00068081

Locations


United States, Arizona
	NeurogesX Investigational Site
	Peoria, Arizona, United States, 85381
	NeurogesX Investigational Site
	Phoenix, Arizona, United States, 85032
	NeurogesX Investigational Site
	Mesa, Arizona, United States, 85210

United States, California
	NeurogesX Investigational Site
	Duarte, California, United States, 91010
	NeurogesX Investigational Site
	Santa Rosa, California, United States, 95403

United States, Florida
	NeurogesX Investigational Site
	Naples, Florida, United States, 34102
	NeurogesX Investigational Site
	Boynton Beach, Florida, United States, 33437
	NeurogesX Investigational Site
	Fort Myers, Florida, United States, 33907
	NeurogesX Investigational Site
	Tampa, Florida, United States, 33614
	NeurogesX Investigational Site
	Bradenton, Florida, United States, 34205

United States, Georgia
	NeurogesX Investigational Site
	Atlanta, Georgia, United States, 30328
	NeurogesX Investigational Site
	Marietta, Georgia, United States, 30060

United States, Massachusetts
	NeurogesX Investigational Site
	Brighton, Massachusetts, United States, 02135

United States, Missouri
	NeurogesX Investigational Site
	St. Louis, Missouri, United States, 63141
	NeurogesX Investigational Site
	St. Louis, Missouri, United States, 63108

United States, North Carolina
	NeurogesX Investigational Site
	Winston-Salem, North Carolina, United States, 27103

United States, Texas
	NeurogesX Investigational Site
	San Antonio, Texas, United States, 78229
	NeurogesX Investigational Site
	Dallas, Texas, United States, 75235

United States, Utah
	NeurogesX Investigational Site
	Salt Lake City, Utah, United States, 84107

Sponsors and Collaborators

NeurogesX